Literature DB >> 7515102

CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.

M Faris1, F Gaskin, J T Parsons, S M Fu.   

Abstract

CD40 plays an important role in B cell activation, proliferation, and Ig class switching. The signal transduction pathway mediated by CD40 was studied using monoclonal antibody (mAb) 626.1 to CD40. Burkitt's lymphoma and Epstein-Barr virus-transformed B cell lines and tonsilar B lymphocytes were treated with the anti-CD40 mAb for various lengths of time. The early events triggered by CD40 were examined by monitoring the changes in tyrosine phosphorylation of cellular proteins with anti-phosphotyrosine mAb. Dephosphorylation of specific proteins ranging between 50-110 kD and the appearance of a 28-kD tyrosine phosphorylated protein were seen within 30 s in human B cell lines. The dephosphorylation was reversed and the 28-kD protein was dephosphorylated in cells stimulated for 1 min. In resting B cells, the appearance of the 28-kD phosphoprotein was observed in 30 s after the addition of the anti-CD40 mAb. The tyrosine phosphorylation of this protein persisted. The patterns of protein tyrosine phosphorylation differed from those induced by an anti-immunoglobulin M mAb. The changes in the state of tyrosine phosphorylation induced by the anti-CD40 mAb were obviated by mAb to CD45, a protein tyrosine phosphatase (PTP) or by the addition of sodium orthovanadate, a broad PTP inhibitor. They were also blocked by protein tyrosine kinase (PTK) inhibitors, herbimycin A and genistein, and PKC and protein serine/threonine kinase inhibitors, H7 and HA1004. In addition, the alteration in the tyrosine phosphorylation of PTKs Lyn, Fyn, and Syk was directly demonstrated. Engagement of CD40 for 30 s induced a transient decrease in tyrosine phosphorylation of these PTKs. These results indicate that the early events in CD40 signaling involve the complex interaction between PTP and protein kinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515102      PMCID: PMC2191516          DOI: 10.1084/jem.179.6.1923

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.

Authors:  R Fuleihan; N Ramesh; R Loh; H Jabara; R S Rosen; T Chatila; S M Fu; I Stamenkovic; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

2.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

Authors:  E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Expression and structure of the human NGF receptor.

Authors:  D Johnson; A Lanahan; C R Buck; A Sehgal; C Morgan; E Mercer; M Bothwell; M Chao
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

4.  Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase.

Authors:  D M Desai; J Sap; J Schlessinger; A Weiss
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

5.  Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45.

Authors:  R R Hovis; J A Donovan; M A Musci; D G Motto; F D Goldman; S E Ross; G A Koretzky
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

6.  Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).

Authors:  J A Ledbetter; G Shu; M Gallagher; E A Clark
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

7.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  Constitutive activation of Src family kinases in mouse embryos that lack Csk.

Authors:  S Nada; T Yagi; H Takeda; T Tokunaga; H Nakagawa; Y Ikawa; M Okada; S Aizawa
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

9.  Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2.

Authors:  C L Ren; T Morio; S M Fu; R S Geha
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Isolation and immunological characterization of a major surface glycoprotein (gp54) preferentially expressed on certain human B cells.

Authors:  C Y Wang; S M Fu; H G Kunkel
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  20 in total

1.  Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.

Authors:  Z Fu; M J Cannon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  CD40 signaling in human dendritic cells is initiated within membrane rafts.

Authors:  P O Vidalain; O Azocar; C Servet-Delprat; C Rabourdin-Combe; D Gerlier; S Manié
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.

Authors:  N J Gallagher; A G Eliopoulos; A Agathangelo; J Oates; J Crocker; L S Young
Journal:  Mol Pathol       Date:  2002-04

4.  Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.

Authors:  N Tsukamoto; N Kobayashi; S Azuma; T Yamamoto; J Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 5.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

6.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

Authors:  A Desai-Mehta; L Lu; R Ramsey-Goldman; S K Datta
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

7.  Characterization of a 23-kDa protein associated with CD40.

Authors:  T Morio; S Hanissian; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 8.  Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands.

Authors:  N Laytragoon-Lewin
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

9.  Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases.

Authors:  I Berberich; G Shu; F Siebelt; J R Woodgett; J M Kyriakis; E A Clark
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

Review 10.  Mechanisms of the pathogenic autoimmune response in lupus: prospects for specific immunotherapy.

Authors:  S K Datta; C Mohan; A Desai-Mehta
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.